Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

SELL
$225.82 - $368.51 $29,356 - $47,906
-130 Closed
0 $0
Q3 2021

Nov 09, 2021

SELL
$221.9 - $484.47 $3,328 - $7,267
-15 Reduced 10.34%
130 $50,000
Q2 2021

Jul 22, 2021

BUY
$129.91 - $234.98 $9,743 - $17,623
75 Added 107.14%
145 $34,000
Q4 2020

Feb 02, 2021

SELL
$65.74 - $169.86 $244,552 - $631,879
-3,720 Reduced 98.15%
70 $7,000
Q3 2020

Oct 15, 2020

SELL
$54.34 - $94.85 $492,863 - $860,289
-9,070 Reduced 70.53%
3,790 $268,000
Q2 2020

Jul 27, 2020

BUY
$29.67 - $80.0 $381,556 - $1.03 Million
12,860 New
12,860 $826,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Evolution Wealth Advisors, LLC Portfolio

Follow Evolution Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.